The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback